DUBLIN--(BUSINESS WIRE)--The "Global Scar Treatment Market Size, Share, Development, Growth and Demand Forecast to 2023" report has been added to Research and Markets' offering.
The global scar treatment market is expected to witness a CAGR of 10.0% during the period 2017 - 2023, and is estimated to reach $34.7 billion by 2023.
Increasing prevalence of skin diseases, rising appearance consciousness among consumers, technological advancements in scar treatment products, increasing awareness among people for scar treatment, and increase in disposable income leading to rise in spending on personal care, are some of the major factors driving the growth of the global scar treatment market.
High cost associated with scar treatment and side effects of scar treatment products and therapies are key challenges in the global scar treatment market.
Silicon-based products, such as gels and gel sheets, are effective for reducing scars and are recommended by cosmetic surgeons and doctors, globally. These products provide effective results and help in fading away of the scars completely.
They are very effective and are used widely for treating all type of scars, including stretch marks, hypertrophic, keloid, acne and post-surgical scars.
The prevalence of skin diseases, such as psoriasis, eczema, vitiligo and photoaging of skin is increasing due to excessive exposure to pollution and ultraviolet radiation, resulting in sunburns, reduced skin elasticity, and hair loss.
Skin diseases are also caused by various other factors, such as excessive alcohol consumption, environmental pollution, and consumption of tobacco.
Key Topics Covered:
1. Research Background
2. Research Methodology
3. Executive Summary
5. Market Size And Forecast By Type Of Treatment
6. Market Size And Forecast By Type Of Scars
7. Market Size And Forecast By End User
8. Global Scar Treatment Market By Geography
9. Competitive Analysis
10. Company Profiles
- Smith & Nephew Plc
- Syneron Medical Ltd.
- Mlnlycke Health Care Ab
- Shanghai Fosun Pharmaceutical (Group) Company Limited.
- Beijing Toplaser Technology Company Limited
- 0Merz Gmbh & Co. Kgaa
- Valeant Pharmaceuticals International Inc.
- Pacific World Corporation
- Avita Medical Limited
- Enaltus Llc
- Sonoma Pharmaceuticals Inc.
- Cca Industries Inc.
- Scarguard Labs Llc
- Quantum Health
- Hologic Inc.
For more information about this report visit https://www.researchandmarkets.com/research/p8wm59/global_scar